Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
Price Target
Average
967.14%
Revenue Forecast
Estimate
66.71%
EBIT
Estimate
5.25%
Net Income
Estimate
--11.44%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
4D Molecular Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for FDMT of $48.9 , with forecasts ranging from
a
low of
$36 to a high of $70 .
FDMT Lowest Price Target
Wall Street Target
36 USD
686.03%
FDMT Average Price Target
Wall Street Target
48.9 USD
967.14%
FDMT Highest Price Target
Wall Street Target
70 USD
1428.38%
REVENUE FORECAST
Revenue Forecast Chart FDMT
EBIT FORECAST
EBIT Forecast Chart FDMT
NET INCOME FORECAST
Net Income Chart FDMT